Evidence map›Paper›PMID 29429901›Full record

Observational studyEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society2018

Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Alan Leviton, Elizabeth N Allred, Raina N Fichorova, T Michael O'Shea, Lynn A Fordham, Karl K C Kuban, Olaf Dammann

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Extreme prematurity: Risk and resiliency.Current problems in pediatric and adolescent health care · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. [Research advances in the biomarkers of brain damage in preterm infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Review
  14. Review
  15. Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Article
  16. Observational
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Alan LevitonBoston Children's Hospital, and Harvard Medical School, Boston, MA, USA. Electronic address: alan.leviton@childrens.harvard.edu.
Elizabeth N AllredBoston Children's Hospital, and Harvard Medical School, Boston, MA, USA.
Raina N FichorovaBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
T Michael O'SheaUniversity of North Carolina, Chapel Hill, NC, USA.
Lynn A FordhamUniversity of North Carolina, Chapel Hill, NC, USA.
Karl K C KubanBoston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Olaf DammannTufts University School of Medicine, Boston, MA, USA.
Harvard University · USUniversity of North Carolina at Chapel Hill · USBoston Medical Center · USBrigham and Women's Hospital · USTufts University · US

Funding

Neonatal Biomarkers in Extremely Preterm Babies Predict Childhood Brain DisordersU01NS040069 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI KUBAN, KARL · 2001 to 2014
$34.0M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
The Role of the Placenta-Brain Axis in Children's NeurodevelopmentUH3OD023348 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Rebecca Fry, Michael O'SHEA · 2018 to 2026
$21.9M
Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm ChildrenUG3OD023348 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRY, REBECCA, O'SHEA, MICHAEL · 2016 to 2024
$7.4M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Circulating Immune Biomarkers and Retinopathy of PrematurityR01EY021820 · NEI · TUFTS UNIVERSITY BOSTON · PI DAMMANN, OLAF · 2013 to 2016
$1.7M
NEI NIH HHS R01 EY021820NICHD NIH HHS P30 HD018655NICHD NIH HHS U54 HD090255NIH HHS UG3 OD023348NIH HHS UH3 OD023348NINDS NIH HHS U01 NS040069
6 · The paper itself

Abstract

aimTo assess to what extent the blood concentrations of proteins with neurotrophic and angiogenic properties measured during the first postnatal month convey information about the risk of sonographically-identified brain damage among very preterm newborns.

methodsStudy participants were 1219 children who had a cranial ultrasound scan during their stay in the intensive care nursery and blood specimens collected on 2 separate days at least a week apart during the first postnatal month. Concentrations of selected proteins in blood spots were measured with electrochemiluminescence or with a multiplex immunobead assay and the risks of cranial ultrasound images associated with top-quartile concentrations were assessed.

resultsHigh concentrations of multiple inflammation-related proteins during the first 2 postnatal weeks were associated with increased risk of ventriculomegaly, while high concentrations of just 3 inflammation-related proteins were associated with increased risk of an echolucent/hypoechoic lesion (IL-6, IL-8, ICAM-1), especially on day 7. Concomitant high concentrations of IL6R and bFGF appeared to modulate the increased risks of ventriculomegaly and an echolucent lesion associated with inflammation. More commonly high concentrations of putative protectors/repair-enhancers did not appear to diminish these increased risks.

conclusionOur findings provide support for the hypothesis that endogenous proteins are capable of either protecting the brain against damage and/or enhancing repair of damage.

Indexed as

Angiogenesis Inducing AgentsBiomarkersBrain InjuriesChildFemaleHumansInfant, Extremely PrematureInfant, NewbornMaleNerve Growth FactorsUltrasonographyAngiogenesis Inducing AgentsBiomarkersNerve Growth FactorsAngiogenesisCytokinesInfantInflammationNeurotrophic factorsPremature/blood

Identifiers

PMID29429901
PMCPMC5899659
OpenAlexW2794026047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.